This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Seradyn, Inc.. Active years: 2010-2013.
Company Filing History:
Years Active: 2010-2013
Title: Melissa Wall: Innovator in Immunoassay Technology
Introduction
Melissa Wall is a prominent inventor based in Avon, IN (US). She has made significant contributions to the field of immunoassays, particularly focusing on lamotrigine analogs. With a total of 2 patents to her name, her work has the potential to impact diagnostic methodologies in the medical field.
Latest Patents
Melissa Wall's latest patents revolve around the development of immunoassays for lamotrigine. The inventions relate to lamotrigine analogs that feature substituents at the triazine 3-position and on the benzene 4-position and 5-position. These analogs can include immunogenic moieties that are instrumental in preparing anti-lamotrigine antibodies. Additionally, they can contain antigenic moieties that are utilized in immunodiagnostic assays for lamotrigine. The lamotrigine analogs also incorporate tracer moieties, which are essential for detecting the presence or quantity of the analog during immunodiagnostic assays. Furthermore, these analogs can compete with lamotrigine for binding with anti-lamotrigine antibodies, enhancing the efficacy of diagnostic tests.
Career Highlights
Melissa Wall is currently employed at Seradyn, Inc., where she continues to innovate in the field of immunoassays. Her work is characterized by a commitment to advancing diagnostic technologies that can improve patient outcomes.
Collaborations
Some of her notable coworkers include Anlong Ouyang and Lili Arabshahi, who contribute to the collaborative environment at Seradyn, Inc. Their teamwork fosters innovation and drives the development of new technologies.
Conclusion
Melissa Wall is a dedicated inventor whose work in immunoassays for lamotrigine is paving the way for advancements in medical diagnostics. Her contributions are significant and reflect her commitment to improving healthcare through innovation.